Aytu BioScience Inc. (AYTU)

[DD2Gain]

The stock was abysmal at $0.35. It looks bad only 33 cents above delisting/reverse split territory that it shot out of largely on promises of millions of dollars in sales that evaporated with a botched deal (Notice how there was never an announcement of millions of "ZOG test kits"). It looks even worse when the CEO follows that collapsed deal with silence and gives himself a raise. To be clear, this company has promising products that are being marketed and some are even FDA approved, but if Disbrow can't get his head out of the COVID-19 hype clouds then there is only trouble for the future.